Ticker Scorecard - ACRS Basics Company: Aclaris Therapeutics, Inc. IPO Date: October 7, 2015 Sector: Healthcare Industry: Biotech Market Cap: $256.84M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 3.16% Avg Daily Range (30 D): $0.06 | 2.30% Avg Daily Range (90 D): $0.10 | 4.04% Institutional Daily Volume Avg Daily Volume: .66M Avg Daily Volume (30 D): .77M Avg Daily Volume (90 D): 1.66M Trade Size Avg Trade Size (Sh.): 156 Avg Trade Size (Sh.) (30 D): 137 Avg Trade Size (Sh.) (90 D): 208 Institutional Trades Total Inst.Trades: 1,168 Avg Inst. Trade: $1.56M Avg Inst. Trade (30 D): $.97M Avg Inst. Trade (90 D): $.96M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.48M Avg Closing Trade (30 D): $1.59M Avg Closing Trade (90 D): $1.43M Avg Closing Volume: 124.71K     News Sep 10, 2024 @ 11:00 AM Aclaris Therapeutics to Participate in the 2024 Ca... Source: N/A Jul 23, 2024 @ 11:31 AM Aclaris Therapeutics And 3 Other Stocks Under $2 I... Source: Avi Kapoor Jul 8, 2024 @ 1:01 PM Aclaris Therapeutics And 1 Other Stock Under $5 In... Source: Avi Kapoor Jun 6, 2024 @ 11:00 AM Aclaris Therapeutics to Participate in the Goldman... Source: Aclaris Therapeutics, Inc. May 7, 2024 @ 9:15 PM Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.52 $-.11 Diluted EPS $-.52 $-.11 Revenue $ 27.08M $ 4.35M $ Gross Profit $ 24.27M $ 3.69M $ Net Income / Loss $ -37M $ -7.59M $ -10.99M Operating Income / Loss $ -46.3M $ -10.47M $ Cost of Revenue $ 2.81M $ .65M $ Net Cash Flow $ 8.61M $ $ PE Ratio